Aster Capital Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-91
Closed -$904 1174
2025
Q3
$904 Buy
+91
New +$947 ﹤0.01% 906
2025
Q2
Sell
-2,946
Closed -$40.6K 1179
2025
Q1
$40.6K Buy
2,946
+2,859
+3,286% +$37.8K 0.01% 864
2024
Q4
$1.11K Sell
87
-829
-91% -$10K ﹤0.01% 1007
2024
Q3
$10.2K Buy
+916
New +$10.1K ﹤0.01% 805

Other funds holding DVAX

Aster Capital Management's DVAX Position: Q4 2025 in Review

Aster Capital Management sold out of Dynavax Technologies (DVAX) in Q4 2025, closing a stake of 91 shares — an estimated $904 sold.

Aster Capital Management first reported a position in DVAX in Q3 2024 and held it in 4 quarters. The position peaked at $40.6K in Q1 2025. 266 funds tracked by Wall St. Rank hold DVAX as of Q4 2025.

  • Aster Capital Management reported no remaining Dynavax Technologies position as of Q4 2025 after selling out during the quarter.
  • Aster Capital Management sold 91 Dynavax Technologies shares in Q4 2025, an estimated $904.
  • Aster Capital Management first reported a position in Dynavax Technologies in Q3 2024 and held it in 4 quarters.
  • Aster Capital Management's Dynavax Technologies position peaked at $40.6K in Q1 2025.
  • 266 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2025.

Based on Aster Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.